Transcranial Direct Current Stimulation for Improving Gait Training in Stroke

Stroke Clinical Trial

Official title:

Using Transcranial Direct Current Stimulation to Jump Start Gait Training in Chronic Stroke Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01807637
• Other study ID #: 138159
• Secondary ID: 138159
• Status: Completed
• Phase: N/A
• Start date: March 1, 2013
• Est. completion date: November 17, 2017

Study information

• Verified date: November 2018
• Source: University of Arkansas
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if transcranial direct current stimulation (tDCS)applied over the lower extremity motor cortex in conjunction with assisted gait training is effective for improving gait in patients with chronic stroke.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: November 17, 2017
• Est. primary completion date: November 17, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• Stroke survivors > 3 months from most recent unilateral, stroke based on clinically or experimentally obtained MRI brain scans and behavioral evidence of stroke (e.g., risk factors, hemiplegia, unilateral sensory impairment, or localized higher cortical dysfunction) by report or in the medical record.

• Age: >21 years of age.

• Complete NIH Stroke Scale.

• Sufficient endurance, motor ability and balance to ambulate at least 10 meters continuously with moderate or less assistance.

• Demonstrate gait impairment during ambulation such that gait instability or inefficient gait patterns [gait pattern manifesting "dragging" or "catching" of the affected toes during swing phase of gait, or use of compensatory strategies such as circumducting the affected limb, vaulting with the unaffected limb or hiking the affected hip to clear the toes] are exhibited.

• Pass the Transcranial Magnetic Stimulation (TMS) Adult Safety Screen (TASS) except for items related specifically to stroke and the treatment for stroke.

Exclusion Criteria:

• Edema, skin breakdown, absent sensation of the affected lower limb which interferes with the peroneal nerve stimulator.

• History of potentially fatal cardiac arrhythmias, such as ventricular tachycardia, supraventricular tachycardia, and rapid ventricular response atrial fibrillation with hemodynamic instability.

• Demand pacemakers or any other implanted electronic systems.

• Pregnant women, uncontrolled seizure disorder, Parkinson's Disease, Spinal cord injury, Traumatic brain injury with evidence of motor weakness, Multiple sclerosis.

• Documented episode in the medical record of a seizure occurring 1 month or more post stroke for which the patient received consultation or treatment for said seizures. Seizures occurring within the first month following a stroke are not exclusionary unless followed by another seizure.

• Fixed ankle plantar flexor contracture, peroneal nerve injury at the fibular head as the cause of foot-drop.

• History of dementia, severely impaired cognition, communication or comprehension deficits.

• Presence of severe or frequent headaches

• History of Botulinum toxin (Botox) injection to either of the lower extremities within the 3 month period preceding study entry.

• Have other medical conditions or are taking medications that compromise ambulation or balance.

• Failure to meet established screening criteria for TMS or tDCS (i.e., TASS)

• Principal Investigator's or Medical Monitor's discretion not to include a participant.

Additional Exclusion Criteria for MRI Scan

• Claustrophobia, or the inability to lie still in a confined space

• Major medical disorders (e.g., HIV, cancer)

• Medications which may affect image quality (e.g., water pills)

• Magnetic metallic implants (such as screws, pins, shrapnel remnants, aneurysm clips, artificial heart valves, inner ear (cochlear) implants, artificial joints, and vascular stents), as these may heat, pull, or twist in the strong magnetic field of the MRI scanner

• Non-removable dental implants, such as braces or permanent retainers, as these will distort the MRI images we collect (note: filings, crowns, and silver or gold teeth are OK)

• Permanent makeup or tattoos with metallic dyes

• A positive pregnancy test (for females), since the effect of strong magnetic fields on the developing fetus remains unknown and inconclusive. (We will conduct a pregnancy test for all female participants on the day of the MRI scan.)

• Psychotic disorders (e.g., schizophrenia)

• Any other condition that the investigator believes might put the participant at risk

Related Conditions & MeSH terms

• Cerebral Vascular Accident
• Stroke

Intervention

Device:
• transcranial direct current stim (tDCS)
During anodal tDCS, participants will receive 20 min at 2mA over motor cortex (with 30 seconds of ramp-up and ramp-down). During sham stimulation the stimulator is turned off.

Locations

Country	Name	City	State
United States	University of Central Arkansas	Conway	Arkansas
United States	University of Arkansas for Medical Sciences	Little Rock	Arkansas

Sponsors (2)

Lead Sponsor	Collaborator
University of Arkansas	University of Central Arkansas

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ankle Dorsiflexion Angle. Change From Baseline in Ankle Dorsiflexion Angle During the Swing Phase of Gait	Over ground laboratory assessments of gait: 1) Gait velocity and spatiotemporal gait parameters will be measured with the GAITRite system (CIR Systems, Inc., Havertown, PA) 28-35. 2) Hip, ankle, and knee angles during gait will be measured using the Simi Aktisys gait analysis system (Simi Reality Motion Systems; Postfach, Unterschleissheim Germany). LED markers are placed on the participant's lower extremity. Ankle, knee, and hip angle data is obtained simultaneously to evaluate motor strategies for overcoming gait impairments. Both types of data will be collected simultaneously as participants walk 10 meters across the GAITRite walkway at a self-selected speed for 5 repetitions.	Study week 1, and study weeks 5(± 5 days) and 8 (± 10 days).
Secondary	Slope of Recruitment Curve. Change From Baseline in the Slope of the Recruitment Curve Based on Motor Evoked Potentials (MEPs).	A Magstim 200 super rapid2 stimulator with a 110 mm double cone coil will deliver stimulation. First, the TMS motor threshold (MT) will be established and the best location for eliciting MEPs from the contralesional and ipsilesional TA muscle will be tracked on the subject's MRI scan in Brainsight. Recruitment curves will be obtained as follows: 1) delivering ten, single TMS pulses beginning at 70% of MT, 2) increasing TMS intensity by 10% and repeating the process up to 160% of the MT or until a plateau in the recruitment curve is reached, 3) offline data processing will be performed with the Matlab curve fitting toolbox and 4) the threshold, slope, and MEPmax, and the goodness of fit (R2) will be calculated. A change in the slope of the recruitment curve will indicate change in cortical excitability.	Study week 1, and study weeks 5(± 5 days) and 8 (± 10 days).
Secondary	Change From Baseline in Stroke Impact Scale Scores	The Stroke Impact Scale-16 (SIS-16, completed by study team) is a standardized instrument 36-38 that assesses 3 functional domains in stroke patients including ADL / IADL, mobility, and social and occupational engagement. It consists of 64 - 5 point likert scale questions with a total score range of 64(lowest) to 320 (highest).	Study week 1, and study weeks 5(± 5 days) and 8 (± 10 days).